Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

ICU delirium drug shows promise in reducing agitation

NCT ID NCT03317067

First seen May 14, 2026 · Last updated May 17, 2026 · Updated 1 time

Summary

This study tested whether a sedative called dexmedetomidine can help calm agitation and shorten delirium in ICU patients who are not on a breathing machine. 168 adults with sudden confusion and agitation took part. The goal was to see if the drug could reduce the time they spent agitated or delirious, and whether it could prevent the need for a breathing tube.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGITATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63003, France

Conditions

Explore the condition pages connected to this study.